集体诉讼案件 - 针对Biohaven Ltd投资者提起的集体诉讼 涉及2023年3月24日至2025年5月14日期间涉嫌证券欺诈造成的损失 [1] - 诉讼指控公司对两种候选药物的监管前景和临床数据存在虚假陈述或隐瞒 [2] - 投资者可在2025年9月12日前申请成为首席原告 但参与赔偿无需担任此角色 [3] 被指控的虚假陈述 - 夸大troriluzole作为脊髓小脑共济失调(SCA)治疗药物的监管前景和提交数据的充分性 [2] - 夸大BHV-7000作为双相情感障碍治疗药物的疗效和临床前景 [2] - 这些虚假陈述一旦曝光可能对公司业务和财务状况产生重大负面影响 [2] 律师事务所背景 - Levi & Korsinsky律所过去20年为受损股东追回数亿美元赔偿 [4] - 拥有70多名员工的专业团队 在复杂证券诉讼领域具有丰富经验 [4] - 连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼律所之一 [4]

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Neogen Corporation ("Neogen Corporation" or the "Company") (NASDAQ: NEOG) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Neogen Corporation investors who were adversely affected by alleged securities fraud between January 5, 2023 and June 3, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/neogen ...

诉讼案件概述 - XPLR Infrastructure LP（前身为Nextera Energy Partners LP）面临证券集体诉讼 投资者因涉嫌证券欺诈可申请索赔 诉讼覆盖时间段为2023年9月27日至2025年1月27日 [1][2] - 诉讼指控公司存在虚假陈述和隐瞒行为 包括运营困难 融资安排风险 以及现金流分配问题 [3] 诉讼指控细节 - 公司作为yieldco运营模式面临持续性挑战 通过特定融资安排暂时缓解问题但未充分披露风险 [3] - 公司在融资到期前无法解决相关问题 可能面临单位持有人权益稀释风险 计划暂停向投资者分配现金以解决融资问题 [3] - 公司公开声明被指控存在重大虚假和误导性 业务模式和分配增长率不可持续 [3] 投资者参与信息 - 受影响投资者可在2025年9月8日前申请作为首席原告参与诉讼 参与索赔无需承担任何自付费用 [4] - 律师事务所Levi & Korsinsky提供专业服务 过去20年为股东追回数亿美元赔偿 在证券诉讼领域具有丰富经验 [5] 公司背景 - 公司股票在纽约证券交易所上市 代码为XIFR 涉及能源基础设施领域 [1]

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Capricor investors who were adversely affected by alleged securities fraud between October 9, 2024 and July 10, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/capricor-therape ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fortrea Holdings Inc. ("Fortrea Holdings Inc." or the "Company") (NASDAQ: FTRE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fortrea Holdings Inc. investors who were adversely affected by alleged securities fraud between July 3, 2023 and February 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/psl ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were adversely affected by alleged securities fraud between June 22, 2023 and June 24, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/sarepta-lawsuit-submi ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of WPP plc (“WPP” or the “Company”) (NYSE: WPP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether WPP and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On July 8, 2025, WPP announced t ...

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CTO Realty Growth, Inc.  (“CTO” or the “Company”) (NYSE: CTO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CTO and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 25, 2025, W ...

诉讼背景 - 律师事务所宣布投资者有机会牵头对Biohaven Ltd (NYSE: BHVN)提起证券欺诈集体诉讼 [1] - 诉讼涉及2023年3月24日至2025年5月14日期间的信息披露问题 [2] 诉讼指控内容 - 公司未披露troriluzole作为SCA治疗药物的监管前景被夸大 [2] - 公司未披露支持troriluzole监管批准的数据充分性存在问题 [2] - 公司未披露BHV-7000作为双相情感障碍治疗药物的疗效和临床前景被夸大 [2] - 上述问题一旦曝光可能对公司业务和财务状况产生重大负面影响 [2] - 公司关于业务、运营和前景的正面陈述存在重大误导或缺乏合理依据 [2] 投资者参与方式 - 投资者需在2025年9月12日前采取行动参与诉讼 [2] - 投资者可通过电子邮件、电话或网站联系律师事务所获取更多信息 [3] - 电子邮件咨询需包含邮寄地址、电话号码和购买股数 [4]